# Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

> **NCT00539162** · NA · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 8000 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BEHAVIORAL:** Questionnaire

## Key facts

- **NCT ID:** NCT00539162
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2001-07-02
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 8000 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539162, "Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00539162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*